Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Features include always present findings: Slowness of movement (bradykinesia), Muscle stiffness (rigidity), Decreased compound muscle action potential amplitude, and Anxiety and others; and very common findings: Decreased motor nerve conduction velocity and Polyneuropathy. 11 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 8 | Resting tremor, Slowness of movement (bradykinesia), Polyneuropathy |
UQCRC1 function has not been fully characterized.
Parkinsonism with polyneuropathy is associated with mutations in the UQCRC1 gene on chromosome 3.
Genetic testing for UQCRC1 is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for parkinsonism with polyneuropathy has been reported in the published literature.
Phenotype severity distribution: 6 always present features, 2 very common features, 3 common features.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for parkinsonism with polyneuropathy.
60 publications have been identified in PubMed for parkinsonism with polyneuropathy. Research spans Case Report / Case Series (27%), Review / Meta-Analysis (22%), and Epidemiology / Natural History (17%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 16 | 27% |
Data assembled from 6 of 12 sources · Last updated Sep 19, 2026, 12:15 AM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Muscles | 2 | Decreased compound muscle action potential amplitude, Diffuse cerebral atrophy |
Research summaries
13 |
22% |
Disease patterns and progression | 10 | 17% |
Laboratory research | 8 | 13% |
Testing and diagnosis research | 5 | 8% |
Clinical study results | 4 | 7% |
Other research | 3 | 5% |
New treatment approaches | 1 | 2% |
Zhang D (2026). [PMID: 41403389](https://pubmed.ncbi.nlm.nih.gov/41403389/). *Mov Disord*. [Case Report / Case Series]
Thatikala A (2026). [PMID: 41505685](https://pubmed.ncbi.nlm.nih.gov/41505685/). *Neurology*. [Case Report / Case Series]
Cochez H (2026). [PMID: 41748281](https://pubmed.ncbi.nlm.nih.gov/41748281/). *Mov Disord*. [Other]
Oreskovic E (2026). [PMID: 41605610](https://pubmed.ncbi.nlm.nih.gov/41605610/). *Br J Ophthalmol*. [Review / Meta-Analysis]
Kessler C (2026). [PMID: 40961460](https://pubmed.ncbi.nlm.nih.gov/40961460/). *Amyotrophic lateral sclerosis & frontotemporal degeneration*. [Epidemiology / Natural History]
Verhamme C (2026). [PMID: 41519594](https://pubmed.ncbi.nlm.nih.gov/41519594/). *Lancet*. [Other]
Agianda HAP (2026). [PMID: 41365832](https://pubmed.ncbi.nlm.nih.gov/41365832/). *Mov Disord*. [Epidemiology / Natural History]
Lan SC (2026). [PMID: 42091683](https://pubmed.ncbi.nlm.nih.gov/42091683/). *Neurol Sci*. [Case Report / Case Series]
Toś M (2026). [PMID: 41919452](https://pubmed.ncbi.nlm.nih.gov/41919452/). *Neurol Neurochir Pol*. [Review / Meta-Analysis]
Friedman AR (2026). [PMID: 41934064](https://pubmed.ncbi.nlm.nih.gov/41934064/). *Best Pract Res Clin Rheumatol*. [Review / Meta-Analysis]